Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Letter to the Editor

GOLD or lower limit of normal definition? a letter and authors’ response

Authors: Philip Quanjer, Carlos A Vaz Fragoso, Martin R Miller, Gülmisal Güder, Stefan Störk, Arno W Hoes, Frans Rutten

Published in: Respiratory Research | Issue 1/2012

Login to get access

Excerpt

Philip H Quanjer, Carlos A Vaz Fragoso and Martin R Miller. …
Literature
1.
Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, Lammers J, Zanen P, Hoes AW, Stork S, Rutten FH: GOLD or lower limit of normal definition?. A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012, 13: 13-10.1186/1465-9921-13-13.PubMedPubMedCentralCrossRef
2.
3.
Sobol BJ, Sobol PG: Percent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax. 1979, 34: 1-3. 10.1136/thx.34.1.1.PubMedPubMedCentralCrossRef
4.
5.
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993, 6 (suppl 16): 5-40.PubMedCrossRef
6.
Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, Rosenthal M, Corey M, Lebecque P, Cole TJ: Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008, 177: 253-260.PubMedPubMedCentralCrossRef
7.
Olofson J, Bake B, Tengelin MN, Houltz B: COPD 'diagnosis’ based on spirometric reference equations. Clin Respir J. 2008, 2 (4): 214-219. 10.1111/j.1752-699X.2008.00065.x.PubMedCrossRef
8.
Marks GB: Are reference equations for spirometry an appropriate criterion for diagnosing disease and predicting prognosis?. Thorax. 2012, 67: 85-87. 10.1136/thoraxjnl-2011-200584.PubMedCrossRef
Metadata
Title
GOLD or lower limit of normal definition? a letter and authors’ response
Authors
Philip Quanjer
Carlos A Vaz Fragoso
Martin R Miller
Gülmisal Güder
Stefan Störk
Arno W Hoes
Frans Rutten
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-61

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue

Research

Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

Research

Stage-dependent association of BDNF and TGF-β1with lung function in stable COPD

Research

Individuals with increased inflammatory response to ozone demonstrate muted signaling of immune cell trafficking pathways

Review

Statins as potential therapeutic drug for asthma?

Research

Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells

Research

Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits